These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12485397)

  • 21. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prions mediated neurodegenerative disorders.
    Huang WJ; Chen WW; Zhang X
    Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4028-34. PubMed ID: 26592824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Truncated forms of the human prion protein in normal brain and in prion diseases.
    Chen SG; Teplow DB; Parchi P; Teller JK; Gambetti P; Autilio-Gambetti L
    J Biol Chem; 1995 Aug; 270(32):19173-80. PubMed ID: 7642585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.
    Hornemann S; Glockshuber R
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perturbation of endoplasmic reticulum homeostasis facilitates prion replication.
    Hetz C; Castilla J; Soto C
    J Biol Chem; 2007 Apr; 282(17):12725-33. PubMed ID: 17329244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases.
    Lorenz H; Windl O; Kretzschmar HA
    J Biol Chem; 2002 Mar; 277(10):8508-16. PubMed ID: 11756421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stimulation of PrP(C) retrograde transport toward the endoplasmic reticulum increases accumulation of PrP(Sc) in prion-infected cells.
    Béranger F; Mangé A; Goud B; Lehmann S
    J Biol Chem; 2002 Oct; 277(41):38972-7. PubMed ID: 12163492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
    Kellershohn N; Laurent M
    Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scrapie susceptibility-linked polymorphisms modulate the in vitro conversion of sheep prion protein to protease-resistant forms.
    Bossers A; Belt PBGM ; Raymond GJ; Caughey B; de Vries R; Smits MA
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4931-6. PubMed ID: 9144167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S; Glockshuber R
    J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.
    Nunziante M; Ackermann K; Dietrich K; Wolf H; Gädtke L; Gilch S; Vorberg I; Groschup M; Schätzl HM
    J Biol Chem; 2011 Sep; 286(39):33942-53. PubMed ID: 21835918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of prion protein genotype and scrapie prion protein type with cellular prion protein charge isoform profiles in cerebrospinal fluid of humans with sporadic or familial prion diseases.
    Schmitz M; Lüllmann K; Zafar S; Ebert E; Wohlhage M; Oikonomou P; Schlomm M; Mitrova E; Beekes M; Zerr I
    Neurobiol Aging; 2014 May; 35(5):1177-88. PubMed ID: 24360565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biology and genetics of prion diseases.
    Prusiner SB
    Annu Rev Microbiol; 1994; 48():655-86. PubMed ID: 7826022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chaperone protein BiP binds to a mutant prion protein and mediates its degradation by the proteasome.
    Jin T; Gu Y; Zanusso G; Sy M; Kumar A; Cohen M; Gambetti P; Singh N
    J Biol Chem; 2000 Dec; 275(49):38699-704. PubMed ID: 10970892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The highways and byways of prion protein trafficking.
    Campana V; Sarnataro D; Zurzolo C
    Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hydrophobic core region governs mutant prion protein aggregation and intracellular retention.
    Biasini E; Tapella L; Restelli E; Pozzoli M; Massignan T; Chiesa R
    Biochem J; 2010 Sep; 430(3):477-86. PubMed ID: 20626348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular and transgenic models of familial prion diseases.
    Harris DA; Chiesa R; Migheli A; Piccardo P; Ghetti B
    Methods Mol Med; 2001; 59():149-61. PubMed ID: 21374503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scrapie prions: a three-dimensional model of an infectious fragment.
    Huang Z; Prusiner SB; Cohen FE
    Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutant prion proteins are partially retained in the endoplasmic reticulum.
    Ivanova L; Barmada S; Kummer T; Harris DA
    J Biol Chem; 2001 Nov; 276(45):42409-21. PubMed ID: 11527974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prion protein conversion in vitro.
    Supattapone S
    J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.